Core Insights - Rapid Micro Biosystems reported record quarterly revenue and increased system placements, indicating strong growth and operational efficiency [6][5][15] Financial Performance - Fourth-quarter revenue rose 37% year-over-year to a record $11.3 million, up from $8.2 million in the prior-year period [5] - Product revenue increased 78% year-over-year to $9.3 million, driven by higher system placements, while consumable revenue rose 11% [3] - Service revenue was $2.0 million, down from $3.0 million a year earlier, attributed to validation timing [3][4] - Total operating expenses were $11.9 million in the fourth quarter, compared to $11.2 million a year earlier [12] - Net loss was $12.5 million, compared to a $9.7 million net loss in Q4 2024, primarily due to inventory charges and lower service margin [13] System Placements and Orders - The company placed 16 Growth Direct systems in the quarter, a record, compared to six placements in the previous quarter [4] - Samsung Biologics is expanding its deployment of the Growth Direct platform through a new multi-system order received in Q1 2026, characterized as a "second wave" larger than the initial order [1] Revenue Guidance and Expectations - For full-year 2026, management expects revenue of $37 million to $41 million, including 30 to 38 system placements [15] - The company anticipates Q1 2026 revenue of at least $7.5 million, with at least five system placements [16] Gross Margin and Cost Management - Fourth-quarter product margin was negative 8%, impacted by a $1.1 million write-off of unusable consumable inventory [8] - Total gross margin for Q4 was negative $0.3 million, or negative 3%, but excluding inventory-related charges, it was 7% [9] - Management expects total gross margin of approximately 20% for the full year 2026, with product margin in the high single digits to low teens [18] Product Development and Future Outlook - The company plans to release a next-generation cloud-native software platform in the second half of 2026, aimed at improving user interface and IT integration [20] - The new platform is in a pre-launch phase with a major customer and is seen as a step toward future AI-driven analytics [20]